Skip to content

Drug interactions

Gilteritinib + Granisetron

Severity: Major

Gilteritinib and Granisetron: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Gilteritinib is labeled for QT prolongation, and granisetron can add a small further effect. The combination raises the risk of serious ventricular arrhythmia, particularly with electrolyte abnormalities.

What this interaction means in plain words

Gilteritinib and Granisetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Gilteritinib belongs to Oncology; Granisetron belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

Additive prolongation of cardiac repolarization.

What to do

Monitor ECG and correct potassium and magnesium. Prefer a non-QT-prolonging antiemetic where possible, and interrupt gilteritinib if QTc becomes markedly prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gilteritinib and Granisetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Gilteritinib with Granisetron?

MediHelp rates the interaction as major. Gilteritinib and Granisetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Gilteritinib is labeled for QT prolongation, and granisetron can add a small further effect. The combination raises the risk of serious ventricular arrhythmia, particularly with electrolyte abnormalities.

How serious is the interaction between Gilteritinib and Granisetron?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and correct potassium and magnesium. Prefer a non-QT-prolonging antiemetic where possible, and interrupt gilteritinib if QTc becomes markedly prolonged.

What other medicines interact with Granisetron?

MediHelp also lists interactions of Granisetron with, for example, Apomorphine, Amiodarone, Amisulpride. The full list is on the Granisetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in